Oruka Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
41.25
|
|
Average Rating
|
4.86
|
|
# Strong Buys
|
6
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.40
|
-1.91
|
-1.51
|
-376.63%
|
|
2024-06-30
|
0.00
|
-2.22
|
0.00
|
0.00%
|
|
2024-03-31
|
0.00
|
-1.66
|
0.00
|
0.00%
|
|
2023-12-31
|
0.00
|
-0.90
|
0.00
|
0.00%
|
|
2023-09-30
|
0.00
|
-1.19
|
0.00
|
0.00%
|
|
2023-06-30
|
0.00
|
-1.23
|
0.00
|
0.00%
|
|
2023-03-31
|
0.00
|
-1.12
|
0.00
|
0.00%
|
|
2022-12-31
|
0.00
|
-0.98
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-5.78
|
|
2023-12-31
|
-4.44
|
|
2022-12-31
|
-8.27
|
|
2021-12-31
|
-16.66
|
|
2020-12-31
|
-29.04
|
|
2019-12-31
|
-54.27
|
|
2018-12-31
|
-124.01
|
|
2017-12-31
|
-391.18
|
|
2016-12-31
|
-391.70
|
|
2015-12-31
|
-487.50
|
|
2014-12-31
|
-716.24
|
|
2013-12-31
|
-2044.33
|
|
2012-12-31
|
-3088.63
|
|
2011-12-31
|
-5052.48
|
|
2010-12-31
|
-9133.80
|
|
2009-12-31
|
-11782.20
|
|
2008-12-31
|
-3984225.19
|
|
2007-12-31
|
-41882.76
|
|
2006-12-31
|
-455913.64
|
|
2005-12-31
|
-313760.06
|
|
2004-12-31
|
-311397.75
|
|
2003-12-31
|
-1234642.30
|
|
2001-12-31
|
-1217235.56
|
|
2000-12-31
|
-266716.81
|